Related Experiment Video
Updated: Jun 6, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Iowa gambling task in Parkinson's disease
Michele Poletti1, Paolo Cavedini, Ubaldo Bonuccelli
1Neurology Unit, Unita Sanitaria Locale of Viareggio, Viareggio, Italy.
Journal of Clinical and Experimental Neuropsychology
|December 9, 2010
Summary
Parkinson's disease (PD) patients show impaired decision-making, particularly when medicated. This cognitive deficit, assessed via the Iowa Gambling Task (IGT), affects reward processing and may link to impulse control disorders in PD.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Neurology
Background:
- Cognitive impairments, including decision-making deficits, are prevalent in Parkinson's disease (PD) even at early stages.
- Medicated PD patients exhibit poorer performance on tasks like the Iowa Gambling Task (IGT) compared to healthy controls, indicating difficulties in adapting choices to changing reward contingencies.
Purpose of the Study:
- To investigate decision-making impairments in Parkinson's disease patients using the Iowa Gambling Task (IGT).
- To explore the role of the orbitofrontal cortex in reward processing and decision-making in PD.
- To discuss potential causal hypotheses for decision-making dysfunction in PD and its relation to impulse control disorders.
Main Methods:
- Assessment of decision-making abilities using the Iowa Gambling Task (IGT).
- Analysis of cognitive performance in medicated Parkinson's disease patients compared to age-matched healthy controls.
- Discussion of neuropathological and dopaminergic therapy effects on orbitofrontal cortex function.
Main Results:
- Medicated PD patients demonstrate significant impairments in decision-making tasks assessing reward contingency learning.
- The Iowa Gambling Task (IGT) performance is affected by factors related to Parkinson's disease, including neuropathology and dopaminergic treatment.
- Orbitofrontal cortex dysfunction is implicated in the observed decision-making deficits.
Conclusions:
- Parkinson's disease and its treatments impact the neural systems crucial for decision-making and reward processing.
- Decision-making impairments in PD may be linked to alterations in orbitofrontal cortex function.
- Further research is warranted to understand the relationship between decision-making deficits, impulse control disorders, and Parkinson's disease progression.
Related Concept Videos
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
